# Effectiveness and Safety of Breeded Leech for Symptomatic Primary Arthrosis of the First Carpometacarpal Joint

> **NCT03020368** · NA · TERMINATED · sponsor: **Charite University, Berlin, Germany** · enrollment: 52 (actual)

## Conditions studied

- Rhizarthrosis

## Interventions

- **BIOLOGICAL:** Leeches
- **DRUG:** Diclofenac

## Key facts

- **NCT ID:** NCT03020368
- **Lead sponsor:** Charite University, Berlin, Germany
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-01
- **Primary completion:** 2018-12
- **Final completion:** 2018-12
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2019-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03020368

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03020368, "Effectiveness and Safety of Breeded Leech for Symptomatic Primary Arthrosis of the First Carpometacarpal Joint". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03020368. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*